Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS ALPHA

Stockholm, 10 January 2022 P Capital today announces that, at the close of business on 31 December 2021, the Net Asset Value of P Capital Partners Alpha participation loan amounted to SEK 719,000 per debenture. Ordinary income of SEK 4,937 per debenture will be distributed to debenture holders on 17 January 2022. A partial repayment of the participation loan debentures amounting to SEK 139,000 per debenture will be made on 31 January 2022. P Capital Partners Alpha’s assets are composed of 100 per cent privately issued corporate loans. During the quarter one private loan was

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS III

Press release Stockholm, 10 January 2022 P Capital today announces that, at the close of business on 31 December 2021, the Net Asset Value per participation loan debentures of P Capital Partners III, was SEK 293,514 for series A and SEK 7,340,684 for series B. No ordinary income will be distributed for the quarter. A partial repayment will be made on 31 January 2022 amounting to SEK 24,000 per series A debenture and SEK 600,000 per series B debenture. P Capital Partners III’s assets are composed of 0.8 per cent publicly traded corporate bonds and 99.2 per cent privately issued

Harri Salo joins Eevia Health Plc as Chief Manufacturing Officer to strengthen top management competence and capacity

Eevia Health Plc, (”Eevia” or ”The Company”), is welcoming Harri Salo as our new Chief Manufacturing Officer. Harri Salo has a 15-year strong career in operations and production management in international industrial business environments. He will start Monday, January 10[th,] and significantly strengthen Eevia Health’s management capacity and competence for developing production organization, operation, and business processes.Harri Salo comes from a position at 9Solutions being responsible for health care delivery projects. Previously, he was head of operations at Specim, responsible for

Kate Bishop appointed Chief Human Resource Officer at IFS

IFS strengthens Executive Leadership Team to build on growth momentumLondon, UK, January 10, 2022 – IFS , the global cloud enterprise software company, today announces the appointment of Kate Bishop as Chief Human Resource Officer. In her role, Bishop will ensure that all aspects of IFS’s HR strategy are future-focused and support the company’s growth plans. Bishop joins the IFS Executive Leadership Team in a period of strong organic and inorganic growth and will continue to drive alignment of the HR function to the global business strategy. As well as focusing on

Sectra appoints new CFO

Linköping, Sweden – January 10, 2022 – Jessica Holmquist has been appointed CFO of international medical imaging IT and cybersecurity company Sectra  (STO: SECT B). Jessica will also become a member of Sectra’s Group Management, taking up her new role in spring 2022.Jessica Holmquist, 45, holds an M.Sc. (Economics and Business) from the Stockholm School of Economics, with a major in accounting and finance, and will bring extensive experience from companies with international operations. Jessica will join Sectra from her role as Business Area Controller Corporate at the

Terrafame pursues annual savings of EUR 10 million and begins change negotiations in accordance with the Finnish Co-operation Act

MEDIA RELEASE In 2021, Terrafame took a significant step towards expanding its business to battery chemicals production. Production ramp up at the new battery chemicals plant started in June, and Terrafame delivered the first batches of products to customers in late 2021. Efficiency and profitability of operations have been the most important goals of Terrafame ever since the company was founded. The company follows a continuous improvement model and is actively seeking ways to improve its profitability. The battery chemicals plant project of the company as well as the launch of the

Corem considers issuance of green SEK bonds and announces tender offer for the outstanding Klövern 2018/2022 SEK bonds

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

Enviro has EUR 32,000 loan converted to grant as a result of establishment in Chile

Enviro has had a previous conditional loan totalling EUR 32,000 (approximately SEK 330,000) converted to a grant without a repayment requirement as a result of the tangible measures the company has taken to establish a recycling plant in Chile. The loan was issued by the Nordic Environment Finance Corporation (NEFCO).N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail. As fund manager for the Nordic Project Fund (Nopef), NEFCO granted Enviro a conditional

Recipharm announces sale of Fontaine-lès-Dijon site to Astrea

Recipharm today announces the sale to Astrea Pharma, the newly established CDMO provider focused on small molecule oral solid and aseptic dosages, of the solid dose manufacturing site at Fontaine-lès-Dijon, France.   Under Recipharm’s ownership, Fontaine has developed extensive experience manufacturing and packaging tablets and capsules. The capabilities fit well with Astrea’s ambitions to grow a broad range of different processing, filling and packaging technologies, as well as a wide geographical reach. Astrea’s owners are seasoned veterans in the CDMO industry and have the

AddSecure completes acquisition of LOSTnFOUND

Together the two companies will provide customers across Europe with comprehensive IoT connectivity solutions that streamline operations and optimize fleets’ utilization.AddSecure , a leading European provider of secure IoT connectivity solutions, today announced that it has completed the acquisition of LOSTnFOUND , a Swiss-based provider of location tracking and fleet management solutions. With this move AddSecure enhances its asset management capabilities in Europe and its expertise within telematics and tracking solutions.

Read original

Glaston Oyj Abp - Managers' Transactions

Glaston Corporation     Stock Exchange Release, Managers' Transactions   10.1.2022 at 11.00Glaston Oyj Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Veli-Matti ReinikkalaPosition: Member of the Board/Deputy member  Issuer: Glaston Oyj AbpLEI: 743700V3I7CLI3DJ8L62 Notification type: INITIAL NOTIFICATIONReference number: 9120/5/4____________________________________________  Transaction date: 2022-01-07Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000369657Nature

AI makes your content work smarter, not harder

Generating quality content, ensuring it reaches the right audience and stays top of mind is a constant struggle for marketers and ecom managers alike. How can we make sure that the best, most captivating visuals are above the fold and helping to boost sales?  Enter the machines. Artificial intelligence and machine learning have been trending since the early 2000s. And as technology has evolved, its potential has branched out from the realm of sci-fi to more practical real-world applications. Now is the time to ask ‘what can AI do for me?’.  At Flowbox, we think the answer

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 8 - 10 JANUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

DAMPSKIBSSELSKABET NORDEN A/S – WEEKLY REPORT ON SHARE BUY-BACK

ANNOUNCEMENT NO. 7 - 10 JANUARY 2022 On 4 November 2021, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 4 November 2021 up to and including no later than end February 2022. For details, please see announcement no. 75 of 4 November 2021. Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 40 million (approximately DKK 263 million).

ABS and HHI Group to Work Together on Autonomous Vessel Projects

WonHo Joo CTO of HHI; KiSun Chung President and CEO of HHI Holdings and KSOE; SungJoon Kim CTO of KSOE: Patrick Ryan, ABS Senior Vice President Global Engineering and Technology; John McDonald, ABS Executive Vice President and COO and DoHyeong Lim CEO of Avikus sign the Strategic Framework Agreement. (LAS VEGAS) ABS and Hyundai Heavy Industries (HHI) are to work together on a series of autonomous projects. ABS specialists will work with HHI’s Korea Shipbuilding and Offshore Engineering (KSOE) and its autonomous navigation subsidiary, Avikus, to integrate autonomous and remote-control

The subscription period in Brighter’s rights issue starts today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, SOUTH AFRICA, CANADA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Today, January 10, 2022, the subscription period for Brighter AB’s (publ) (“Brighter” or the “Company”) upcoming rights issue of units, which was announced on November 4, 2021 (the “Rights Issue”), begins. The subscription period in the Rights Issue runs from and including January 10, 2022, to and including January 24,

myFC getting ready to deliver proof-of-concept – fuel cell bicycle system for global manufacturer

myFC's development project for the operation of electric bicycles together with a well-known manufacturer of bicycle systems is approaching delivery.– The project has kept to the schedule and the result looks very good, says Sebastian Weber, CTO at myFC.The process with the proof-of-concept started in the summer of 2021. Together with the customer, a supplier of bicycle systems with a global market, myFC started to develop a system adapted for electric bicycles where the company's technology with microfuel cells is combined with a lithium-ion battery, which increases use time and have the

Balco Group updates its financial targets

Balco Group's Board of Directors has decided to update the Group's financial targets. A new target for earnings per share replaces the previous margin target, the dividend policy is adjusted and a new sustainability target linked to the sale of energy-saving measures is introduced. The targets for growth and interest-bearing net debt remain at the same level as before.New target: Earnings per share shall grow by 20 percent per year Balco Group’s financial target for operating margin (EBIT) is replaced by earnings per share growing by 20 percent per year. – The main task for Balco

Cyxone step up activities and extend collaboration with global CRO around RA trial

Cyxone (publ) announces today that the company has signed a Letter of Agreement (LOA) with the internationally renowned clinical contract research organization (CRO) following on an early operations agreement (EOA) signed last month. The LOA is a key step for advancing the clinical phase 2b trial of Rabeximod in patients with rheumatoid arthritisThe agreement enables Cyxone to expand and intensify start-up activities for the phase 2b trial including site selections and regulatory submissions enabling an efficient route to enrolling patients into the trial within the shortest period of time.

GET Group AB (publ) announces the outcome for exercising warrants of series TO1

The period for exercising warrants of series TO1 ("Warrants") for subscription of shares in GET Group AB (publ) ("GET Group" or "the Company") ended on 30 December 2021. A total of 18,746,225 Warrants were exercised for subscription of 18,746,225 shares, corresponding to an exercise rate of approximately 45.7 percent, and the Company receives SEK 1.95 million before issue costs.Background The Company completed during December 2020 a rights issue of units consisting of one (1) new share and one (1) free of charge warrant of series TO1. In total, 41,008,175 warrants of series TO1 were

Major end-of-year transaction in 2021 on the Baltic real estate market – East Capital Real Estate has signed an agreement for the sale of three properties

In December 2021, East Capital Real Estate signed an agreement for the sale of three properties located in Tallinn, Estonia and the surrounding area: the J13 Logistics Park, the Rimi Logistics Park, and the Metro Plaza Office Building. The total gross leasable area of the buildings is 66,000 square metres. The buyer of the assets is OÜ Neoinvesteeringud.The J13 Logistics Park is located in Tänassilma, on the outskirts of Tallinn, and consists of two buildings with a gross leasable area of 40,000 square metres. East Capital Baltic Property Fund II has been the owner and manager of the

Atlas Copco’s Q4 report 2021 and invitation to the conference call, January 25

Nacka, Sweden, January 10, 2022: Atlas Copco will publish its Q4 results for 2021 on Tuesday, January 25, at approximately 12:00 PM CET. A conference call for investors, analysts and media will be held at 2:00 PM CET.Participating from Atlas Copco will be Mats Rahmström, President and CEO, and Peter Kinnart, CFO. The conference call will begin with a short presentation of the report followed by a question-and-answer session. The conference call will be broadcasted live on the web. Please see our website www.atlascopcogroup.com/investor-relations for the webcast link and presentation

Implantica to present at Digital Medicine & Medtech Showcase 2022

Implantica AG (publ) announces today that its founder and CEO, Peter Forsell, is presenting, Implantica – the future of eHealth, in an online presentation at the Digital Medicine & Medtech Showcase taking place virtually on January 10-12 and January 17-19, 2022.In his presentation, Peter Forsell shares Implantica’s eHealth and wireless energised technology platforms and prioritised products as well as RefluxStop™, the CE marked product to treat acid reflux. Implantica’s video presentation was made available by the Digital Medicine & Medtech Showcase to registered participants on its

There are no items matching the current filter
There are no more items matching the current filter
Back to top